The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York BPC 157 and TB 500: Injury Healing Peptides Jonathan L. Glashow posted on the topic LinkedIn FDA takes first step in possible reversal of ban on some peptides The Washington Post FDA Moves to Reevaluate Several Peptides American Med Spa Association Peptide Law: A Healthcare Attorney's Guide to the FD&C Act and Unapproved Drugs Holt Law